Anaphylaxis to leuprolide acetate depot injection during treatment for prostate cancer

Clinical Genitourinary Cancer

Volumn 5, Issue 4, 2007, Pages 284-286

  Grant Jr , John P ^a   Levinson, Adam W ^b  

^a Department of Urology   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Androgen deprivation; Antineoplastic agents; Gonadorelin; Neoadjuvant therapy

Indexed keywords

LEUPRORELIN;

AGED; ANAPHYLAXIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTUBATION; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 34249869057     PISSN: 15587673     EISSN: None     Source Type: Journal    
DOI: 10.3816/CGC.2007.n.005     Document Type: Article

References (20)

1. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effects of casttation, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1:293-297.
2. Sanofi-aventis. Prescribing information for leuprolide acetate for injectable suspension Eligard. Available at: http://www.sanofi-aventis.us. Accessed December 10, 2005.
3. Potters L, Torre T, Ashley R, et al. Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy. J Clin Oncol 2000; 18:1187-1192.
4. Merrick GS, Butler WM, Wallner KE, et al. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005; 61:32-43.
5. Miyamoto H, Messing EM, Chang C. Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate 2004; 61:332-353.
6. Lee LN, Stock RG, Stone NN. Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation. Int J Radiat Oncol Biol Phys 2000; 52:444-452.
7. Bolla M, Gonzalez D, Warde P, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997; 337:295-300.
8. D'Amico AV, Manola J, Loffredo M, et al. 6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer. JAMA 2004; 292:821-827.
9. Messing EM, Manola J, Sarosdy M, et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancet. N Engl J Med 1999; 341:1781-1788.
10. Clinical trial endpoints in prostate cancer. Presented at: FDA Public Workshop; June 21-22, 2004; Bethesda, MD.
11. Approval package for: application number 21-343 (Eligard 7.5mg), March 2001. Center for Drug Evaluation and Research. Available at: http://www.fda.gov. Accessed December 14, 2005.
12. Approval package for: application number 21-379 (Eligard 22.5mg), June 2002. Center for Drug Evaluation and Research. Available at: www.fda.gov. Accessed December 14, 2005.
13. Abarelix [package insert]. Available at http://www.fda.gov/cder/foi/ label/2003/021320lbl.pdf. Accessed December 14, 2005.
14. Potashnik G, Lunenfeld E, Spitz E, et al. Anaphylactic reaction to gonadotropin-releasing hormone. N Engl J Med 1993; 328:815.
15. Popovic V, Milosevic Z, Djukanovic R, et al. Hypersensitivity reaction with intravenous GnRH after pulsatile subcutaneous GnRH treatment in male hypogonadotrophic hypogonadism. Postgrad Med J 1988; 64:245-246.
16. Stoianov K. Anaphylacrogenic properties of Bulgarian gonadotropic preparations [in Bulgarian]. Vet Med Nauki 1979; 16:74-80.
17. Biffimi M, Battaglia A, Bottelli F, et al. Allergenic potential of gonadotrophs preparations in experimental animals: relevance of purity. Hum Reprod 1994; 9:1845-1848.
18. Hatika G, Gabriel R, Quereux C, et al. Hypersensitization to human menopausal gonadotropins with anaphylactic shock syndrome during a fifth in vitro fertilization cycle. J Assist Reprod Genet 1994; 11:51-53.
19. Letterie GS, Stevenson D, Shah A. Recurrent anaphylaxis to a depot form of GnRH analogue. Obstet Gynecol 1991; 78:943-946.
20. Taylor JD. Anaphylactic reaction to the GNRH analogue, leuptolin. Med J Aust 1994; 161:455.